Recombinant multi-species PDE4C protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PDE4C protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene belongs to the cyclic nucleotide phosphodiesterase (PDE) family, and PDE4 subfamily. This PDE hydrolyzes the second messenger, cAMP, which is a regulator and mediator of a number of cellular responses to extracellular signals. Thus, by regulating the cellular concentration of cAMP, this protein plays a key role in many important physiological processes. Alternatively spliced transcript variants encoding different isoforms have been described for this gene.[provided by RefSeq, Jul 2011]
The Alternative Names of target: 3',5'-cyclic-AMP phosphodiesterase 4C,DPDE1,Dpde1,E130301F19Rik,PDE21,PDE4C,Pde4c,cAMP-specific phosphodiesterase 4C,dunce
Go
to PDE4C products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-T12081-Ag-1/ GM-Tg-hg-T12081-Ag-2 | Human PDE4C protein | Human |
| GM-Tg-rg-T12081-Ag-1/ GM-Tg-rg-T12081-Ag-2 | Rat PDE4C protein | Rat |
| GM-Tg-mg-T12081-Ag-1/ GM-Tg-mg-T12081-Ag-2 | Mouse PDE4C protein | Mouse |
| GM-Tg-cynog-T12081-Ag-1/ GM-Tg-cynog-T12081-Ag-2 | Cynomolgus/Rhesus macaque PDE4C protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-T12081-Ag-1/ GM-Tg-felg-T12081-Ag-2 | Feline PDE4C protein | Feline |
| GM-Tg-cang-T12081-Ag-1/ GM-Tg-cang-T12081-Ag-2 | Canine PDE4C protein | Canine |
| GM-Tg-bovg-T12081-Ag-1/ GM-Tg-bovg-T12081-Ag-2 | Bovine PDE4C protein | Bovine |
| GM-Tg-equg-T12081-Ag-1/ GM-Tg-equg-T12081-Ag-2 | Equine PDE4C protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-T12081-Ag-1/ GM-Tg-hg-T12081-Ag-2;
GM-Tg-rg-T12081-Ag-1/ GM-Tg-rg-T12081-Ag-2;
GM-Tg-mg-T12081-Ag-1/ GM-Tg-mg-T12081-Ag-2; GM-Tg-cynog-T12081-Ag-1/ GM-Tg-cynog-T12081-Ag-2; GM-Tg-felg-T12081-Ag-1/ GM-Tg-felg-T12081-Ag-2; GM-Tg-cang-T12081-Ag-1/ GM-Tg-cang-T12081-Ag-2; GM-Tg-bovg-T12081-Ag-1/ GM-Tg-bovg-T12081-Ag-2; GM-Tg-equg-T12081-Ag-1/ GM-Tg-equg-T12081-Ag-2 |
| Products Name | PDE4C protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | PDE4C |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PDE4C protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.